We contribute to promoting human health by expanding frontiers, accelerating research, and reducing risks of drug discovery.
Who We Are
Researchers at the Graduate School of Medicine, The University of Tokyo, have developed new technologies to measure GPCR activities with extraordinary sensitivity and specificity. They co-founded Tanso Biosciences to apply their innovation and revolutionize GPCR drug discovery.
With its assay platform, Tanso Biosciences promotes human health by expanding frontiers, accelerating research, and reducing drug development risks. Tanso Biosciences is an academic spin-off and occupies university incubator spaces at the main campus in the central district of Tokyo. One of the co-founders, Hideaki Ogasawara, MD, PhD, MBA serves as Chief Executive Officer.
We coined the name Tanso by combining the kanji characters 探 (tan, exploration) and 創 (soh, creation) to indicate our aspirations of innovating a drug discovery platform and developing new drugs on it.
Send us a message via the form below or write to us at firstname.lastname@example.org.
Service Flow Chart
Request for Quotation
Tell us about the types of tests you need, the number of compounds, the receptors of interest, and other preferences. A non-disclosure agreement is optional.
A non-disclosure agreement is optional.
The client ships test compounds to our laboratory. We usually perform assays and write a report in three weeks from the receipt of the compounds.
Receipt of the Report
We provide the report and raw data for the client via email or a cloud service.